All-Cause Mortality and Gastrointestinal Adverse Effects in Adults With Type 2 Diabetes on Glucagon-Like Peptide-1 Receptor Agonists vs Sodium-Glucose Cotransporter-2 Inhibitors Article (Web of Science)

cited authors

  • Garg, Samita; Qapaja, Thabet; Hamid, Osama; Kaya, Gizem; Abdel-Razeq, Rashid; Alayan, Dina; Abu-Rumaileh, Mohammed; Lembo, Anthony; Nissen, Steven

publication date

  • January 1, 2025

webpage

published in

category

keywords

  • GLP-1 receptor agonists
  • Gastroin-testinal adverse effects
  • Gastroparesis
  • SGLT-2 inhibitor
  • Type 2 diabetes

volume

  • 4

issue

  • 10